UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Virulence Factors of Avian Pathogenic Escherichia Coli Strains Isolated from Chickens with Colisepticemia in Japan

Avian diseases, 2007-09, Vol.51 (3), p.656-662

2007

Volltextzugriff (PDF)

VIRULENCE FACTORS OF AVIAN PATHOGENIC ESCHERICHIA COLI STRAINS ISOLATED FROM CHICKENS WITH COLISEPTICEMIA IN JAPAN

Avian diseases digest, 2007-09, Vol.2 (3), p.e19-e19

2007

Volltextzugriff (PDF)

Impact of Diabetes Mellitus on Rehospitalization for Heart Failure Among Survivors of Acute Myocardial Infarction in the Percutaneous Coronary Intervention Era

Circulation Journal, 2009, Vol.73(4), pp.662-666

2009

Volltextzugriff (PDF)

Serum antibody levels and the course of anemia-parasitemia in dogs inoculated with Babesia gibsoni

Nihon saikingaku zasshi, 1983-07, Vol.38 (4), p.687-693

1983

Volltextzugriff (PDF)

The course of parasitemia and development of specific antibodies in the dogs inoculated with Babesia gibsoni

Nippon Saikingaku Zasshi, 1983/07/25, Vol.38(4), pp.687-693

1983

Volltextzugriff (PDF)

A HER2-Targeting Antibody-Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model

Molecular cancer therapeutics, 2018-07, Vol.17 (7), p.1494-1503

2018

Volltextzugriff (PDF)

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

Cancer science, 2016-07, Vol.107 (7), p.1039-1046

2016

Volltextzugriff (PDF)

A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization

Clinical cancer research, 2019-12, Vol.25 (23), p.7151-7161

2019

Volltextzugriff (PDF)

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Clinical cancer research, 2016-10, Vol.22 (20), p.5097-5108

2016

Volltextzugriff (PDF)

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

International journal of cancer, 2017-10, Vol.141 (8), p.1682-1689

2017

Volltextzugriff (PDF)

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

The lancet oncology, 2017-11, Vol.18 (11), p.1512-1522

2017

Volltextzugriff (PDF)

Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis

Clinical cancer research, 2021-07, Vol.27 (14), p.3970-3979

2021

Volltextzugriff (PDF)

Metabolic machinery encrypted in the Raman spectrum of influenza A virus‐inoculated mammalian cells

Journal of cellular physiology, 2020-06, Vol.235 (6), p.5146-5170

2020

Volltextzugriff (PDF)

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model

The journal of physiological sciences, 2019-11, Vol.69 (6), p.885-893

2019

Volltextzugriff (PDF)

Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice

Xenobiotica, 2020-10, Vol.50 (10), p.1242-1250

2020

Volltextzugriff (PDF)

Novel polymer-ceramic nanocomposite based on high dielectric constant epoxy formula for embedded capacitor application

Journal of applied polymer science, 2002-01, Vol.83 (5), p.1084-1090

2002

Volltextzugriff (PDF)

Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty

American journal of medical genetics. Part A, 2024-05, Vol.194 (10), p.e63726

2024

Volltextzugriff (PDF)

Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads

Bioorganic & medicinal chemistry letters, 2016-03, Vol.26 (6), p.1542-1545

2016

Volltextzugriff (PDF)

The prenatal causes of slight lateral ventricular enlargement in infants treated in a neonatal intensive care unit

The journal of maternal-fetal & neonatal medicine, 2022-01, Vol.35 (25), p.7551-7554

2022

Volltextzugriff (PDF)

Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology

Bioorganic & medicinal chemistry letters, 2016-10, Vol.26 (20), p.5069-5072

2016

Volltextzugriff (PDF)

Final adult height in long-term growth hormone-treated achondroplasia patients

European journal of pediatrics, 2017-07, Vol.176 (7), p.873-879

2017

Volltextzugriff (PDF)

Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy

Clinical cancer research, 2023-06, Vol.29 (12), p.2239-2249

2023

Volltextzugriff (PDF)

Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions

PloS one, 2014-01, Vol.9 (1), p.e86367-e86367

2014

Volltextzugriff (PDF)

Differential Dynamics of Humoral and Cell-Mediated Immunity with Three Doses of BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers in Japan: A Prospective Cohort Study

Vaccines (Basel), 2022-06, Vol.10 (7), p.1050

2022

Volltextzugriff (PDF)

Current Status of Neonatal Transport at our Center

Journal of Japan Society of Perinatal and Neonatal Medicine, 2023, Vol.59(3), pp.349-353

2023

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(25)
Animals
(16)
Humans
(14)
Mice
(11)
Oncology
(10)
Engineering
(9)
Female
(9)
Technology
(9)
Engineering, Electrical & Electronic
(8)
Camptothecin - Analogs & Derivatives
(7)
Male
(7)
Antibodies, Monoclonal, Humanized - Pharmacology
(5)
Camptothecin - Pharmacology
(5)
Cell Line, Tumor
(5)
Ceramics
(5)
Dielectric Constant
(5)
Immunoconjugates - Pharmacology
(5)
Topoisomerase I Inhibitors - Pharmacology
(5)
Trastuzumab
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Virulence Factors of Avian Pathogenic Escherichia Coli Strains Isolated from Chickens with Colisepticemia in Japan

VIRULENCE FACTORS OF AVIAN PATHOGENIC ESCHERICHIA COLI STRAINS ISOLATED FROM CHICKENS WITH COLISEPTICEMIA IN JAPAN

Impact of Diabetes Mellitus on Rehospitalization for Heart Failure Among Survivors of Acute Myocardial Infarction in the Percutaneous Coronary Intervention Era

Serum antibody levels and the course of anemia-parasitemia in dogs inoculated with Babesia gibsoni

The course of parasitemia and development of specific antibodies in the dogs inoculated with Babesia gibsoni

A HER2-Targeting Antibody-Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis

Metabolic machinery encrypted in the Raman spectrum of influenza A virus‐inoculated mammalian cells

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model

Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice

Novel polymer-ceramic nanocomposite based on high dielectric constant epoxy formula for embedded capacitor application

Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty

Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads

The prenatal causes of slight lateral ventricular enlargement in infants treated in a neonatal intensive care unit

Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology

Final adult height in long-term growth hormone-treated achondroplasia patients

Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy

Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions

Differential Dynamics of Humoral and Cell-Mediated Immunity with Three Doses of BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers in Japan: A Prospective Cohort Study

Current Status of Neonatal Transport at our Center

Suchergebnisse filtern